Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00475761 · ClinicalTrials.gov registry record

Breast Mammogram and Tissue Study

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
466
Enrollment target

NCT00475761: Completed study, sponsored by National Cancer Institute (NCI).

NCT00475761 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 466 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add start date to calendar (.ics) →

The verdict

NCT00475761 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
466 participants
Enrollment target

Study Summary

Background: Women whose mammograms show a lot of dense areas are more likely to develop breast cancer and to have cancers that are missed by mammograms. It is unclear why some factors lead to having dense breasts and why having dense breasts increases the risk of developing breast cancer. Objectives: To determine why some women s breasts look dense on mammograms. To determine what types of cells and tissues make up dense areas of breasts and why these tissues may be more likely to become cancerous. Eligibility: Women between 40 and 65 years of age who have not had breast cancer or received medicines or radiation for any type of cancer and who are scheduled to undergo a breast biopsy. Design: This study is conducted at the University of Vermont, in collaboration with the NCI. Participants undergo the following: * Review of their medical records collected over the last 2 years by the Vermont Mammography Registry. * Participation in a short telephone interview. * Height and weight measurement. * Testing of biopsy tissue collected for diagnosis or treatment. * Future contacts regarding health status for up to 10 years, including review of additional mammograms, removed tissues, questionnaires and medical records collected by the Vermont Mammography Registry during the 10-year study. Participants may also undergo the following optional procedures: * Provide a mouthwash sample for genetic testing. * Provide a blood sample to test for markers of dense mammograms or breast cancer.

Primary Outcome

Feasibility of collecting data needed from pilot to report the preliminary results from the pilot data in published manuscripts.

Trial Details

FieldValue
Enrollment Target 466 participants
Start Date 2007-05-11
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00475761 record still lists

NCT00475761 is an observational study that tracks outcomes without assigning an intervention. The registered 466 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00475761 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00475761 about?

NCT00475761 is a clinical study titled "Breast Mammogram and Tissue Study". Background: Women whose mammograms show a lot of dense areas are more likely to develop breast cancer and to have cancers that are missed by mammograms. It is unclear why some factors lead to having dense breasts and why having dense breasts increases the risk of developing breast cancer. Objecti...

What is the current status of trial NCT00475761?

This trial is currently completed. The enrollment target is 466 participants. The study started on 2007-05-11.

Who is sponsoring clinical trial NCT00475761?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05312879 · 466 participants · Phase 2

    Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease

  • NCT06917404 · 466 participants · Phase 3

    A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

  • NCT07055165 · 466 participants · NA

    Connect2Care: Prostate Cancer Education and Screenings for African American Men

  • NCT07214779 · 466 participants · Phase 3

    Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00475761, the US trial registry maintained by the National Library of Medicine. NCT00475761 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.